Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 6/20 | 0.51 |
| ▸ | REN | P00797 | 3/20 | 0.49 |
| ▸ | GRB2 | P62993 | 1/20 | 0.48 |
| ▸ | TLR2 | O60603 | 1/20 | 0.48 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29129170 | 1.00 | PTPN1 (0.51) | PTPN1RENGRB2TLR2TLR1 | |
| SCHEMBL29613446 | 0.95 | PTPN1 (0.50) | PTPN1RENGRB2TLR2TLR1 | |
| SCHEMBL29129048 | 0.91 | KMT2A (0.49) | PTPN1GRB2TLR2TLR1KMT2A | |
| SCHEMBL29129044 | 0.91 | KMT2A (0.49) | PTPN1GRB2TLR2TLR1KMT2A | |
| SCHEMBL29431191 | 0.91 | MDM2 (0.51) | PTPN1TLR2TLR1KMT2A | |
| SCHEMBL30193403 | 0.91 | MDM2 (0.52) | PTPN1TLR2TLR1KMT2A | |
| SCHEMBL30193389 | 0.91 | MDM2 (0.52) | PTPN1TLR2TLR1KMT2A | |
| SCHEMBL18421240 | 0.91 | MDM2 (0.52) | PTPN1TLR2TLR1KMT2A | |
| SCHEMBL16870002 | 0.91 | MDM2 (0.52) | PTPN1TLR2TLR1KMT2A | |
| SCHEMBL16870156 | 0.91 | MDM2 (0.52) | PTPN1TLR2TLR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117279636-A | Methods and compounds for modulating myotonic muscular dystrophy type 1 | 设计治疗公司 | 2023-12-22 | — | — | CN | disclosed |